Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-23 Purchase |
2024-12-27 5:16 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
555,556 | $0.45 | $250,000 | 1,713,920 (Direct) |
View |
| 2024-09-03 Purchase |
2024-09-05 12:03 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
37,894 | $0.76308 | $28,916 | 47,252 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-09 Option Award |
2024-12-10 4:47 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
536,603 | $0 | 536,603 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:11 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
80,965 | $0 | 80,965 (Direct) |
View |
Ownership |
2023-01-03 09:47 am |
N/A N/A |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
0 | $0 | 990,051,600 (Direct) |
View |